KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories' Lead Sericulture Expert Joins Recombinant Spider Silk Production Team at New Rearing Facility in Southeast Asia

Kraig Biocraft Laboratories' Lead Sericulture Expert Joins Recombinant Spider Silk Production Team at New Rearing Facility in Southeast Asia

ANN ARBOR, Mich., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that Dr. Nirmal Kumar, the Company's lead sericulture expert, has arrived in Southeast Asia to support the production team at its recently established second rearing facility.

Dr. Kumar will work directly with the Company's operations team on the first production cycle at the new center, ensuring the highest levels of quality and efficiency as Kraig Labs continues to expand its BAM-1 spider silk output. His expertise in silkworm rearing and hybrid development has been instrumental to the Company's success, and his on-site leadership marks a significant step for Kraig Labs in its transition to continuous production of BAM-1, its first recombinant spider silk hybrid line.

During this time with the team, Dr. Kumar will also oversee the build-out of an expanded BAM-1 egg production center and testing lab, designed to support ongoing scale-up and maintain production continuity across multiple rearing centers. These facilities will form the backbone of the Company's long-term commercialization strategy as Kraig Labs ramps BAM-1 production to meet growing demand.

Additionally, Dr. Kumar will explore opportunities with secondary processing providers in the region, including spinners capable of supporting downstream applications for recombinant spider silk. As part of this effort, Kraig Labs is currently in discussions with a potential customer regarding a custom order of spider silk thread, a crucial step toward demonstrating the versatility and scalability of BAM-1 in specialty textile markets.

"Having Dr. Kumar on the ground with our production team at this critical stage provides invaluable expertise with our second rearing center now fully online," said Kim Thompson, Kraig Labs' Founder and CEO. "His leadership not only strengthens our current BAM-1 production cycle but also sets the stage for the expansion and processing partnerships that will allow us to meet near-term customer opportunities and long-term market demand."

The Company's ability to execute on both upstream production and downstream processing highlights its unique position at the intersection of biotechnology and traditional sericulture, as Kraig Labs works to establish spider silk as a commercial reality.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit .

For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel .

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to

* For a description of our historical leadership in this technology, please follow this link

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495



EN
02/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

24/7 Market News: Sportswear and Smart Textiles are likely Key Spider ...

24/7 Market News: Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs DENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights the opportunity for recombinant spider silk produced by Kraig Biocraft Laboratories (OTCQB: KBLB), the global leader in the development and commercialization of spider silk. 24/7 Market News believes that some of the most obvious projected use-cases include compression gear, perspiration-wicking layers, temperature-regulating b...

 PRESS RELEASE

24/7 Market News: Kraig Labs Offers Safer, Natural Alternative to Heal...

24/7 Market News: Kraig Labs Offers Safer, Natural Alternative to Health Risks from Nylon and Polyester Clothing DENVER, Sept. 26, 2025 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories’ (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, spider silk will be set to play a crucial role in the emerging public health concerns linked to everyday wear of nylon and polyester apparel, both of which are petroleum-based plastics know...

 PRESS RELEASE

Kraig Biocraft Laboratories Successfully Completes First Parallel Two-...

Kraig Biocraft Laboratories Successfully Completes First Parallel Two-Facility Production Cycle, Establishing Model for Continuous Recombinant Spider Silk Supply Chain ANN ARBOR, Mich., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the successful completion of its first simultaneous production cycle across two independent rearing centers. This milestone verifies the Company's multi-facility production model designed to increase throughput, enhance supply chain resil...

 PRESS RELEASE

24/7 Market News: Kraig Labs Eco-Engineered Spider Silk Poised to Rede...

24/7 Market News: Kraig Labs Eco-Engineered Spider Silk Poised to Redefine Sports Apparel DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, is positioning itself at the forefront of a new frontier in sportswear innovation as it prepares to reconvene its recombinant spider silk production program. Kraig Labs plans on delivering the first spider silk fi...

 PRESS RELEASE

Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pur...

Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center ANN ARBOR, Mich., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing the acquisition of an additional silkworm rearing center as part of its ongoing multi-facility expansion strategy to produce its revolutionary recombinant spider silk. This planned addition builds on the significant production growth and operational advancements achieve...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch